These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 27001652)
1. Serum IFN-γ-inducible chemokines CXCL9 and CXCL10 are elevated in non-immediate drug hypersensitivity reactions. Wang F; Cai R; He D; Zhao Y; Ye Y; Zhang X Asian Pac J Allergy Immunol; 2016 Sep; 34(3):236-241. PubMed ID: 27001652 [TBL] [Abstract][Full Text] [Related]
2. Chemokine expression in diverse nonimmediate drug hypersensitivity reactions: focus on thymus activation-regulated chemokine, cutaneous T-cell-attracting chemokine, and interleukin-10. Wang F; He D; Tang X; Zhang X Ann Allergy Asthma Immunol; 2014 Aug; 113(2):204-8. PubMed ID: 24932689 [TBL] [Abstract][Full Text] [Related]
3. Altered levels of complement components associated with non-immediate drug hypersensitivity reactions. Wang F; Huang L; Yu J; Zang D; Ye L; Zhu Q J Immunotoxicol; 2020 Dec; 17(1):1-9. PubMed ID: 31795786 [TBL] [Abstract][Full Text] [Related]
4. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs. Fernandez TD; Mayorga C; Torres MJ; Cornejo-Garcia JA; López S; Chaves P; Rondon C; Blanca M Allergy; 2008 Jun; 63(6):712-9. PubMed ID: 18384452 [TBL] [Abstract][Full Text] [Related]
5. CXCL9 and CXCL10 are differentially associated with systemic organ involvement and pulmonary disease severity in sarcoidosis. Arger NK; Ho ME; Allen IE; Benn BS; Woodruff PG; Koth LL Respir Med; 2020 Jan; 161():105822. PubMed ID: 31783271 [TBL] [Abstract][Full Text] [Related]
6. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases. Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215 [TBL] [Abstract][Full Text] [Related]
7. Serum CXCL11 correlates with pulmonary outcomes and disease burden in sarcoidosis. Arger NK; Ho M; Woodruff PG; Koth LL Respir Med; 2019 Jun; 152():89-96. PubMed ID: 31128616 [TBL] [Abstract][Full Text] [Related]
8. Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity. Hasan Z; Jamil B; Khan J; Ali R; Khan MA; Nasir N; Yusuf MS; Jamil S; Irfan M; Hussain R Scand J Immunol; 2009 Mar; 69(3):259-67. PubMed ID: 19281538 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of CXCL1, CXCL9, CXCL10 and CXCL12 chemokines in alopecia areata. Zainodini N; Hassanshahi G; Arababadi MK; Khorramdelazad H; Mirzaei A Iran J Immunol; 2013 Mar; 10(1):40-6. PubMed ID: 23502337 [TBL] [Abstract][Full Text] [Related]
10. Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines. Edvardsen K; Bjånesøy T; Hellesen A; Breivik L; Bakke M; Husebye ES; Bratland E J Interferon Cytokine Res; 2015 Oct; 35(10):759-70. PubMed ID: 25978633 [TBL] [Abstract][Full Text] [Related]
11. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ]. Lin Q; Song Y; Zhu X; Yang S; Zheng J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):137-40. PubMed ID: 23388331 [TBL] [Abstract][Full Text] [Related]
12. Interferon-inducible chemokines reflect severity and progression in sarcoidosis. Su R; Nguyen ML; Agarwal MR; Kirby C; Nguyen CP; Ramstein J; Darnell EP; Gomez AD; Ho M; Woodruff PG; Koth LL Respir Res; 2013 Nov; 14(1):121. PubMed ID: 24199653 [TBL] [Abstract][Full Text] [Related]
13. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes. Kanda N; Shimizu T; Tada Y; Watanabe S Eur J Immunol; 2007 Feb; 37(2):338-50. PubMed ID: 17274000 [TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations. Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988 [TBL] [Abstract][Full Text] [Related]
15. Plasma IFN-γ-inducible chemokines CXCL9 and CXCL10 correlate with survival and chemotherapeutic efficacy in advanced pancreatic ductal adenocarcinoma. Qian L; Yu S; Yin C; Zhu B; Chen Z; Meng Z; Wang P Pancreatology; 2019 Mar; 19(2):340-345. PubMed ID: 30685120 [TBL] [Abstract][Full Text] [Related]
16. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides. Shimauchi T; Sugita K; Nishio D; Isoda H; Abe S; Yamada Y; Hino R; Ogata M; Kabashima K; Tokura Y J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665 [TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome. Caldarale F; Giacomelli M; Garrafa E; Tamassia N; Morreale A; Poli P; Timpano S; Baresi G; Zunica F; Cattalini M; Moratto D; Chiarini M; Cannizzo ES; Marchetti G; Cassatella MA; Taddio A; Tommasini A; Badolato R Front Immunol; 2021; 12():654587. PubMed ID: 33841438 [TBL] [Abstract][Full Text] [Related]
18. [PPAR-γ agonist inhibits the expressions of chemokines induced by IFN-γ and TNF-α in renal tubular epithelial cells]. Song Y; Lin Q; Zheng J; Zhu X; Yang S Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):673-6. PubMed ID: 25001926 [TBL] [Abstract][Full Text] [Related]
19. [Effect of chemokines CXCL9 and CXCL10 on bone erosion in patients with rheumatoid arthritis]. Zhong H; Xu LL; Bai MX; Su Y Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1026-1031. PubMed ID: 34916676 [TBL] [Abstract][Full Text] [Related]
20. Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens. Oliver BG; Elliott JH; Price P; Phillips M; Cooper DA; French MA J Acquir Immune Defic Syndr; 2012 Nov; 61(3):287-92. PubMed ID: 22732467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]